Financhill
Back

BioXcel Therapeutics Quote, Financials, Valuation and Earnings

BioXcel Therapeutics Price Quote

$20.41
+0.01 (+-2.53%)
(Updated: June 9, 2023 at 5:25 AM ET)

BioXcel Therapeutics Key Stats

Buy
55
BioXcel Therapeutics (BTAI) is a Buy

Day range:
$20.00 - $20.99
52-week range:
$8.80 - $34.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
11.22%

Volume:
440.1K
Avg. volume:
582.7K
1-year change:
74.06%
Market cap:
$594.9M
Revenue:
$375K
EPS:
$-6.63

How Much Does BioXcel Therapeutics Make?

Data Unavailable

Is BioXcel Therapeutics Growing As A Company?

Data Unavailable

BioXcel Therapeutics Stock Price Performance

What Is BioXcel Therapeutics 52-Week High & Low?

BioXcel Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioXcel Therapeutics?

Is BioXcel Therapeutics Cash Flow Positive?

  • What Is BTAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$155.3M
  • What Is BioXcel Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $120.4M
  • What Is BioXcel Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19K

BioXcel Therapeutics Return On Invested Capital

Data Unavailable

BioXcel Therapeutics Earnings Date & Stock Price

BioXcel Therapeutics Competitors

  • Who Are BioXcel Therapeutics's Competitors?
    Below is a list of companies who compete with BioXcel Therapeutics or are related in some way:
    • Akebia Therapeutics Inc (AKBA)
    • Aldeyra Therapeutics Inc (ALDX)
    • Axsome Therapeutics Inc (AXSM)
    • Precision BioSciences Inc (DTIL)
    • Vertex Pharmaceuticals Inc (VRTX)

BioXcel Therapeutics Dividend Yield

Data Unavailable

BioXcel Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -16.06%
Revenue: 0% -36.37%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 51.30
Upside from Last Price: 151.47%

Major Shareholders

  • How many BTAI shares are owned by institutional investors?
    27.3M BTAI shares are owned by institutional investors
  • How many BTAI shares are owned by insiders?
    173.7K BTAI shares are owned by insiders